UNSPSC 85533381: Bypass portal vein to lower vein with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass portal vein to lower vein with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06183DY

UNSPSC 85533381 Bypass portal vein to lower vein with intraluminal device, percutaneous approach (Commodity) shows little relevant recent activity under the code's nominal scope. The source contains six recent state and local procurement opportunities, none of which involve vascular interventional procedures or medical devices matching the code name. Instead, the opportunities span independent medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing—all distinct from percutaneous vascular intervention and the devices that code describes. The mismatch suggests either that state and local procurement systems are using this code incorrectly for general healthcare contracting, or that the code itself has limited practical application in state and local markets relative to its clinical definition.

The six opportunities identified do span multiple issuing bodies—city retirement offices (Phoenix), municipal health plans (Long Beach), state transportation departments (Washington State Department of Transportation), county juvenile justice systems (Harris County), county benefits consortiums (Collier County), and regional health systems (Santa Clara County). However, none of these opportunities are actually soliciting for the vascular intervention device or procedure that UNSPSC 85533381 names. Without opportunities that match the code's intended scope, business development professionals targeting state and local procurement under this Commodity code should verify whether the code is being applied at all in their target markets, or whether demand exists only at the federal level or in specialty clinical settings outside traditional government procurement channels.